Changes in oral corticosteroid use in asthma treatment—A 20-year Danish nationwide drug utilisation study
| Autor: | Daniel Pilsgaard Henriksen, Hanne Madsen, Anton Pottegård, Inge Raadal Skov, Jesper Rømhild Davidsen |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2022 |
| Předmět: |
Adult
Male Pediatrics medicine.medical_specialty pharmacoepidemiology Adolescent Denmark Prednisolone Administration Oral Toxicology Danish Cohort Studies Young Adult medicine Prevalence adults Humans Anti-Asthmatic Agents Registries Young adult Adverse effect Glucocorticoids Asthma Pharmacology glucocorticoids business.industry Drug utilisation General Medicine Pharmacoepidemiology Middle Aged asthma medicine.disease language.human_language Drug Utilization Cohort language drug utilisation Female business medicine.drug |
| Zdroj: | Skov, I R, Henriksen, D P, Madsen, H, Pottegård, A & Davidsen, J R 2022, ' Changes in oral corticosteroid use in asthma treatment—A 20-year Danish nationwide drug utilisation study ', Basic & Clinical Pharmacology & Toxicology, vol. 130, no. 1, pp. 122-131 . https://doi.org/10.1111/bcpt.13680 |
| Popis: | Oral corticosteroids (OCS) are used in asthma management but can cause serious adverse effects. We aimed to investigate the usage trends in a nationwide asthma cohort in Denmark from 1999 to 2018. Using national registers, we identified young adults (18–45 years) with two or more asthma drug collections within 12 months since the age of 15 years as indicative of active asthma. OCS exposure level was stratified as high use (≥5 mg prednisolone/day/year) and low use ( |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|